CHALLENGES IN CURRENT SOURCING OF ARTEMISININ - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

CHALLENGES IN CURRENT SOURCING OF ARTEMISININ

Description:

CHALLENGES IN CURRENT SOURCING OF ARTEMISININ. ARTEMISININ ... Ipca is a pharmaceutical company manufacturing ... Re-crystallization for recovery ... – PowerPoint PPT presentation

Number of Views:738
Avg rating:3.0/5.0
Slides: 23
Provided by: dcj2
Category:

less

Transcript and Presenter's Notes

Title: CHALLENGES IN CURRENT SOURCING OF ARTEMISININ


1
CHALLENGES IN CURRENT SOURCING OF
ARTEMISININ ARTEMISININ ENTERPRISE
CONFERENCE October 8-10, York, UK By DR.
D.C. JAIN GREEN TECHNOLOGY DEPARTMENT Ipca
Laboratories Ltd. India
2
  • BRIEF ABOUT IPCA LABORATORIES
  • Ipca is a pharmaceutical company manufacturing
    globally marketing formulation active
    pharmaceutical ingredients (APIs)
  • One of the larger manufacturer in the world of
    APIs like Atenol, Porpranolol, Chloroquine
    salts, Artemisinin derivatives (Artemether,
    Arteether /Artesunate) Etc.
  • Mission Malaria Ipca launched mission malaria in
    2008 committed to the cause of helping to save
    over a million lives lost every year.
  • Some facts to address global issues
  • Ipca is Indias market leader in anti malaria in
    all dosage forms.
  • Ipca is one of the world larger manufacturer of
    Artemisinin based APIs and formulations.
  • WHO Geneva has approved our API Formulation
    antimalarial plants.
  • Ipca is the only company which is into production
    of formulations. APIs and crop cultivation.
  • Now Ipca has a broad range of antimalarial APIs
    Formulations with strong backward integration
    by manufacturing most antimalarial APIs to back
    up formulations.

3
IPCA LABORATORIES LTD. INDIA
4
Green Mission
5
  • GREEN MISSION OF IPCA
  • Artemisia annua plant introduction in
    India - 1985-86
  • Commercially viable variety developed -
    1990,97 2001
  • (Asha, Jeevan Raksha and CIM-Arogya
  • Ipca initiated the cultivation - 2001
  • Commercial Cultivation - 2004-05
  • Cultivation in different state of country - 300
    Hac Land
  • Major Achievements
  • Average yield / Ha. - 2-2.2 tons / Hac.
  • Average artemisinin content - 0.8
  • Recovery of artemisinin - 70 72
  • New area of cultivation - 500Hac. (South
    India)

6
Artemisia cultivation in Different States of India
Now approaching Bio-Technology through
cultivation of Artemisia Annua plant
Gujrat, Madhya Pradesh, Uttar Pradesh,
Uttaranchal, Chattisgarh, Rajashtan, AP, Karnataka
7
CULTIVATION IN DIFFERENT LOCATIONS
Madhya Pradesh
Gujrat
Uttaranchal
Rajasthan
8
FIELD VIEW OF ARTEMISIA ANNUA
9
OUR EXPERIENCE IN CULTIVATION
10
OUR EXPERIENCE IN CULTIVATION IN SOUTH INDIA
11
  • SOURCING OF ARTEMISININ
  • WHY OWN SOURCING
  • Quality of material
  • Consistent supply
  • Cheaper cost of ACTs and Formulation
  • Reduce dependency
  • Source of new drugs (Cancer Etc.)
  • By products Fuel / Bio fertilizers / Mosquito
    repellent

12
  • CHALLENGES TO PRODUCTION OF ARTEMSININ
  • Higher cost of raw material (Dry Artemisia
    leaves)
  • Low content of artemisinin
  • High cost of production
  • Major impurity of artemisinin
  • Prices fluctuation.

13
  • CHALLENGES OF SOLUTION FOR LOW COST DRY LEAVES
  • Reduce the cultivation cost
  • High dry leaves yield / Hac.
  • Increase the farmer benifits
  • No reduction of food grain area.
  • Cultivation at waste land of government.
  • Development of rainy season crop
  • Problem
  • Flowering in the month of September October
    (Rainy season in India)
  • Challenge
  • To develop non flowering crop in this period.

14
ARTEMISIA PLANT DEVELOPED BY TISSUE CULTURE (LAB
TO FIELD)
15
  • MAIN IMPURITY OF ARTEMISNIN
  • Main impurity of artemisinin upto 10
  • Separation is difficult increased cost of
    production
  • Main impurity identified as artemisitene
  • Problem-
  • Carry forward the similar arte-derivatives as
    impurity
  • Removal of impurity from arte-products Loss of
    yield Cost increase.
  • Solution
  • Impurities should be reduce
  • Carry forward - Product study of impurity.
  • Conversion to artemisinin.

16
  • GLOBAL CHALLENGES IN LARGE SCALE PRODUCTION OF
    ARTEMISININ
  • High yielding variety of region specific.
  • Identification of best production areas.
  • Increasing productivity per hectare.
  • Lack of good quality seed availability.
  • Link production with processing.
  • Combination between agri sector, Health
    Environment
  • Processing and post harvest constrains.
  • Loss of artemisinin during drying and storage of
    dry leaves

17
  • NEW SOURCE OF ARTEMISININ
  • New high yielding variety under development at
    York University.
  • Semi synthetic artemisinin (US Berkelly)
  • (Fermentation (E. Coli) Artemisinic acid
    Artemisinin)
  • Plant Chicory New source of dihydro artemisinic
    acid ? Artemisinin
  • New Source Artemisinic Acid
  • Selection of high yielding artemisinic acid
    variety
  • Artemisinic acid is stable molecule.
  • Easily isolate from plant.
  • Less problem of artemisinin impurity
  • Challenges
  • High conversion of artemisinic acid to
    Artemisinin (Chemical / Enzymatic)

18
  • CHALLENGES OF EXTRACTION AND RECOVERY OF
    ARTEMISININ FROM PRIMARY EXTRACTS
  • Extraction of different solvent systems results
    complex mixture containing unwanted compounds.
  • Variation due to different variety, climatic
    conditions and geographic variations,
  • Re-crystallization for recovery of artemisinin
  • Higher loss of artemisinin, solvent traces,
    Hazardous nature/negative environment health
    extracts.
  • Crystalline artemisinin obtained by column
    chromatography.
  • Trace impurity in crystalline artemisinin has
    negative effect on derivatization.
  • Complex Challenges Maximizing yield of
    artemisinin from plant and achieving required
    purity of consecutive derivatization.

19
  • CHOICE FOR EXTRACTION TECHNOLOGY
  • ULTRASONIC ASSISTED EXTRACTION
  • Benifits
  • Selective extraction compressed to other
    techniques
  • Versatile technique that allows small scale to
    large scale.
  • Short extraction times rooms temperature
    operation.
  • Avoiding damage of temperature sensitive
    compounds.
  • Improved yield can be extracted in comparison to
    other method.
  • Excellent solution for extraction of
    phytochemicals.

20
  • CHALLENGES IN ANALYSIS
  • No single well defined and validated analytical
    approved protocol for quantitative analysis of
    artemisinin especially low concentration.
  • Essential to quantify loss of artemisinin at each
    process stages From harvest to chromatography.
  • Reliable analytical protocol for quantitative
    analysis of artemisinin in the leaf, primary
    extract and crystalline phase.
  • No information in public domain which trace
    compounds are problematic for derivatization of
    artemisinin.
  • Library of reliable standards of most known
    compounds found in A. annua

21
IMPACT OF MISSION
  • Artemisinin is a future drug of choice.
  • Artemisia annua is a plant of future.
  • New source of anticancer drug.
  • Cultivation increases the rural employment.
  • Avoid dependency.
  • Environment Friendly
  • Consistency in Quality

22
THANK YOU
IPCA LABORATORIES LTD. INDIA
Write a Comment
User Comments (0)
About PowerShow.com